Top AngioDynamics Executive Makes Bold Stock Purchase!
Lawrence T. Weiss, Senior VP of AngioDynamics, purchased 10,000 shares worth $118,100, signaling confidence in the company. AngioDynamics reported a 12.2% increase in Q1 net sales to $75.7 million, driven by Med Tech growth. Canaccord raised its price target to $18 due to strong results and guidance. Despite challenges like tariff expenses and losses, the outlook remains optimistic. Spark rates ANGO as Neutral, citing mixed financial performance but strong technical momentum. Current market cap is $487M with a YTD price performance of 30.29%.
Lawrence T. Weiss, the Senior Vice President and Chief Legal Officer of AngioDynamics, has made a significant investment by purchasing 10,000 shares of the company’s stock. This transaction is valued at $118,100, indicating a strong vote of confidence in the company’s future prospects.
Recent Updates on ANGO stock
In the last 24 hours, AngioDynamics has reported strong financial results for Q1 of fiscal year 2026, with a 12.2% increase in net sales to $75.7 million, driven by a 26.1% growth in the Med Tech segment. This growth was fueled by platforms such as Auryon, AngioVac, and NanoKnife. The company also achieved significant clinical milestones, including the enrollment of the first patients in the AMBITION BTK and RECOVER-AV trials, and the publication of the NanoKnife PRESERVE study results. Canaccord raised its price target for AngioDynamics to $18, citing better-than-expected Q1 results and raised guidance, highlighting the company’s momentum and strategic investments in R&D and commercial teams. Despite facing challenges such as tariff expenses and adjusted net losses, AngioDynamics’ increased guidance and strategic initiatives indicate a promising future.
Spark’s Take on ANGO Stock
According to Spark, TipRanks’ AI Analyst, ANGO is a Neutral.
AngioDynamics’ overall stock score reflects a mixed outlook. The most significant factor is the company’s financial performance, which is challenged by negative profitability and cash flow issues. However, the technical analysis shows strong momentum, and the positive earnings call with increased guidance provides optimism for future performance. Valuation concerns remain due to the negative P/E ratio and lack of dividend yield.
To see Spark’s full report on ANGO stock, click here.
More about AngioDynamics
YTD Price Performance: 30.29%
Average Trading Volume: 472,197
Technical Sentiment Signal: Buy
Current Market Cap: $487M
